PREVENTION AND TREATMENT OF OSTEOPOROSIS IN COMORBID PATIENTS

The article analyzes the effectiveness of existing drugs for the treatment and prevention of osteoporosis. The role of calcium and vitamin D in bone tissue homeostasis is shown. Special attention is paid to one of the urgent pharmacological and therapeutic problems – polypragmasia associated with comorbidity. Research data demonstrate that drugs for the basic therapy of cardiovascular diseases do not have undesirable interactions with drugs for the treatment of osteoporosis and, in general, many of them have a positive effect on bone metabolism and bone strength. One of the solutions to the problems associated with the treatment of osteoporosis may be the use of biologically active additives Osteomed, Osteo-Vit D3, Osteomed Forte.